1121 Walkers Line
Unit 3A
Burlington, ON L7N 2G4
Canada
(416) 477-1052
https://rapid-dose.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Mark Andrew Upsdell | Founder, President, CEO & Director | 155.6k | N/A | N/A |
Mr. Douglas Alan Hyland C.A., CPA | Chief Financial Officer | 369.38k | N/A | N/A |
Mr. Jason Lewis | Senior Vice President of Business Development | 155.6k | N/A | N/A |
Ben Macphail M.Sc. | Chief Scientist | N/A | N/A | N/A |
Mr. Donald Alexander-R. Sheldon B.A.Sc., L.L.B., LL.B, M.A.Sc., P.Eng. | Legal Counsel | N/A | N/A | 1947 |
Rishi Kapadia | Controller | N/A | N/A | N/A |
Jorge Estepa | Assistant Corporate Secretary | N/A | N/A | N/A |
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.
Rapid Dose Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.